Detalhe da pesquisa
1.
Effect of lipophilicity on drug distribution and elimination: Influence of obesity.
Br J Clin Pharmacol
; 87(8): 3197-3205, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33450083
2.
HLA associations with infliximab-induced liver injury.
Pharmacogenomics J
; 20(5): 681-686, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32024945
3.
Clinical Consequences of Altered Drug Disposition in Obesity: Call for Change.
J Clin Pharmacol
; 63 Suppl 2: S25-S34, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37942910
4.
Incomplete Data and Potential Risks of Drugs in People with Obesity.
Curr Obes Rep
; 12(4): 429-438, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37980304
5.
Estimation of Absolute and Relative Body Fat Content Using Noninvasive Surrogates: Can DXA Be Bypassed?
J Clin Pharmacol
; 63 Suppl 2: S35-S47, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37942909
6.
Drug Disposition in Subjects With Obesity: The Research Work of Darrell R. Abernethy.
J Clin Pharmacol
; 62(11): 1350-1363, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35661375
7.
Impact of Obesity on Brexpiprazole Pharmacokinetics: Proposal for Improved Initiation of Treatment.
J Clin Pharmacol
; 62(1): 55-65, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34339048
8.
Brexpiprazole Pharmacokinetics in CYP2D6 Poor Metabolizers: Using Physiologically Based Pharmacokinetic Modeling to Optimize Time to Effective Concentrations.
J Clin Pharmacol
; 62(1): 66-75, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34328221
9.
Progressive multifocal leukoencephalopathy genetic risk variants for pharmacovigilance of immunosuppressant therapies.
Front Neurol
; 13: 1016377, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36588876
10.
Germline Genetic Risk Variants for Progressive Multifocal Leukoencephalopathy.
Front Neurol
; 11: 186, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32256442